Human Immunodeficiency Virus/human Parvovirus B19 Co-infection in Blood Donors and AIDS Patients in Sichuan, China

Overview

Journal Blood Transfus

Specialty Hematology

Date 2012 Jul 14

PMID 22790259

Citations 10

Authors

Miao He

Jiang Zhu

Huimin Yin

Ling Ke

Lei Gao

Zhihong Pan

Xiuhua Yang

Wuping Li

Affiliations

Soon will be listed here.

Abstract

Background: Human parvovirus B19 (B19) is a common pathogen which causes a variety of diseases. Persistent B19 infection is related to the degree of host immunodeficiency in patients with human immunodeficiency virus (HIV) infection. However, the existence, loading, virus evolution and distribution of B19 in Chinese HIV-positive patients have not been determined.

Materials And Methods: We investigated 573 HIV-positive blood donors and AIDS patients in Sichuan, China in the last two decades. Bl9-specific serology and quantitative polymerase chain reaction were used to determine the prevalence of B19/HIV co-infection. Viral genome fragments were subjected to phylogeny and haplotype analysis.

Results: B19 genomic DNA was found in 26 of 573 (4.5%) HIV-positive individuals, a higher prevalence than in blood donors. DNA levels ranged from 5.3×10(2)-1.1×10(5) copies/mL. The seroprevalence of IgG was significantly lower in HIV-positive samples than in HIV-negative blood donors, indicating deficient production of B19-specific IgG in the former. The B19 isolates were genotype-1 subtype B19-1A which formed a monophyletic group; seven distinct haplotypes were discovered with 60% of the B19/HIV co-infected variants sharing one central haplotype.

Discussion: This study on the prevalence, phylogeny and distribution of human parvovirus B19 in Sichuan, China, demonstrates the persistence of B19 in the circulation of both immunocompetent and immunocompromised subjects, with implications for blood safety.

Citing Articles

Prevalence and genotypic characterization of human parvovirus B19 in hemophilia patients.

Keshavarz M, Janati-Namin N, Arjeini Y, Mokhtari-Azad T, Rezaei F Iran J Microbiol. 2023; 14(4):568-573.

PMID: 36721508 PMC: 9867637. DOI: 10.18502/ijm.v14i4.10244.

Molecular and serological markers of human parvovirus B19 infection in blood donors: A systematic review and meta-analysis.

Farahmand M, Tavakoli A, Ghorbani S, Monavari S, Kiani S, Minaeian S Asian J Transfus Sci. 2021; 15(2):212-222.

PMID: 34908757 PMC: 8628227. DOI: 10.4103/ajts.ajts_185_20.

The human parvovirus B19/human immunodeficiency virus co-infection in healthy eligible voluntary blood donors at the Blood Transfusion National Center in Kinshasa.

Alain C, Antoine L, Bizette B, Dahlia P, Dophie T, Jeremie M Pan Afr Med J. 2020; 35:69.

PMID: 32523647 PMC: 7255965. DOI: 10.11604/pamj.2020.35.69.21018.

Association between Parvovirus B19 and anemia in HIV-infected patients.

Nouri M, Kamakifar P, Khodabandehlou N, Nahand J, Tavakoli A, Norooznezhad F Med J Islam Repub Iran. 2020; 33:137.

PMID: 32280643 PMC: 7137816. DOI: 10.34171/mjiri.33.137.

Molecular prevalence of parvovirus B19 among HIV1-infected patients in Iran.

Kiani S, Javanmard D, Ghaffari H, Tavakoli A, Mortazavi H, Bokharaei-Salim F Med J Islam Repub Iran. 2019; 32:113.

PMID: 30815408 PMC: 6387811. DOI: 10.14196/mjiri.32.113.

References

Sanabani S, Kleine Neto W, Pereira J, Sabino E . Sequence variability of human erythroviruses present in bone marrow of Brazilian patients with various parvovirus B19-related hematological symptoms. J Clin Microbiol. 2006; 44(2):604-6. PMC: 1392653. DOI: 10.1128/JCM.44.2.604-606.2006. View

Shade R, Blundell M, Cotmore S, Tattersall P, Astell C . Nucleotide sequence and genome organization of human parvovirus B19 isolated from the serum of a child during aplastic crisis. J Virol. 1986; 58(3):921-36. PMC: 253001. DOI: 10.1128/JVI.58.3.921-936.1986. View

Frickhofen N, Young N . Persistent parvovirus B19 infections in humans. Microb Pathog. 1989; 7(5):319-27. DOI: 10.1016/0882-4010(89)90035-1. View

Frickhofen N, Abkowitz J, Safford M, Berry J, Astrow A, Cohen R . Persistent B19 parvovirus infection in patients infected with human immunodeficiency virus type 1 (HIV-1): a treatable cause of anemia in AIDS. Ann Intern Med. 1990; 113(12):926-33. DOI: 10.7326/0003-4819-113-12-926. View

Norja P, Hokynar K, Aaltonen L, Chen R, Ranki A, Partio E . Bioportfolio: lifelong persistence of variant and prototypic erythrovirus DNA genomes in human tissue. Proc Natl Acad Sci U S A. 2006; 103(19):7450-3. PMC: 1464359. DOI: 10.1073/pnas.0602259103. View

Toan N, Duechting A, Kremsner P, Song L, Ebinger M, Aberle S . Phylogenetic analysis of human parvovirus B19, indicating two subgroups of genotype 1 in Vietnamese patients. J Gen Virol. 2006; 87(Pt 10):2941-2949. DOI: 10.1099/vir.0.82037-0. View

Shackelton L, Holmes E . Phylogenetic evidence for the rapid evolution of human B19 erythrovirus. J Virol. 2006; 80(7):3666-9. PMC: 1440363. DOI: 10.1128/JVI.80.7.3666-3669.2006. View

Ronquist F, Huelsenbeck J . MrBayes 3: Bayesian phylogenetic inference under mixed models. Bioinformatics. 2003; 19(12):1572-4. DOI: 10.1093/bioinformatics/btg180. View

Parsyan A, Szmaragd C, Allain J, Candotti D . Identification and genetic diversity of two human parvovirus B19 genotype 3 subtypes. J Gen Virol. 2007; 88(Pt 2):428-431. DOI: 10.1099/vir.0.82496-0. View

10.

Kooistra K, Mesman H, de Waal M, Koppelman M, Zaaijer H . Epidemiology of high-level parvovirus B19 viraemia among Dutch blood donors, 2003-2009. Vox Sang. 2010; 100(3):261-6. DOI: 10.1111/j.1423-0410.2010.01423.x. View

11.

Corcoran A, Doyle S . Advances in the biology, diagnosis and host-pathogen interactions of parvovirus B19. J Med Microbiol. 2004; 53(Pt 6):459-475. DOI: 10.1099/jmm.0.05485-0. View

12.

Bremner J, Beard S, Cohen B, Alimenti A, Cantiniaux B, Levy J . Secondary infection with parvovirus B19 in an HIV-positive patient. AIDS. 1993; 7(8):1131-2. DOI: 10.1097/00002030-199308000-00021. View

13.

Hokynar K, Soderlund-Venermo M, Pesonen M, Ranki A, Kiviluoto O, Partio E . A new parvovirus genotype persistent in human skin. Virology. 2002; 302(2):224-8. DOI: 10.1006/viro.2002.1673. View

14.

Stamatakis A, Hoover P, Rougemont J . A rapid bootstrap algorithm for the RAxML Web servers. Syst Biol. 2008; 57(5):758-71. DOI: 10.1080/10635150802429642. View

15.

Nguyen Q, Wong S, Heegaard E, Brown K . Identification and characterization of a second novel human erythrovirus variant, A6. Virology. 2002; 301(2):374-80. DOI: 10.1006/viro.2002.1585. View

16.

Norja P, Eis-Hubinger A, Soderlund-Venermo M, Hedman K, Simmonds P . Rapid sequence change and geographical spread of human parvovirus B19: comparison of B19 virus evolution in acute and persistent infections. J Virol. 2008; 82(13):6427-33. PMC: 2447064. DOI: 10.1128/JVI.00471-08. View

17.

Bizjak G, Blondin D, Hammer R, Kozlowski P, Siegmann H, Stressig R . Acute infection with parvovirus B19 in early pregnancy. Ultrasound Obstet Gynecol. 2009; 34(2):234-5. DOI: 10.1002/uog.6454. View

18.

Thomas I, Di Giambattista M, Gerard C, Mathys E, Hougardy V, Latour B . Prevalence of human erythrovirus B19 DNA in healthy Belgian blood donors and correlation with specific antibodies against structural and non-structural viral proteins. Vox Sang. 2003; 84(4):300-7. DOI: 10.1046/j.1423-0410.2003.00299.x. View

19.

Nguyen Q, Sifer C, Schneider V, Bernaudin F, Auguste V, Garbarg-Chenon A . Detection of an erythrovirus sequence distinct from B19 in a child with acute anaemia. Lancet. 1998; 352(9139):1524. DOI: 10.1016/S0140-6736(05)60330-3. View

20.

Parsyan A, Candotti D . Human erythrovirus B19 and blood transfusion - an update. Transfus Med. 2007; 17(4):263-78. DOI: 10.1111/j.1365-3148.2007.00765.x. View